Open AccessUsing antifibrinolytics in the peripartum period – concern for a hypercoagulable effect?
Author(s) -
Homa K. Ahmadzia,
E.L. Lockhart,
Samantha M. Thomas,
Ian J. Welsby,
Matthew R. Hoffman,
Allison James,
Amy Murtha,
Geeta K. Swamy,
Chad A. Grotegut
Publication year - 2017
Publication title -
journal of neonatal-perinatal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.444
H-Index - 17
eISSN - 1934-5798
pISSN - 1878-4429
DOI - 10.3233/npm-16139
Subject(s) - period (music) , medicine , philosophy , aesthetics
Although antifibrinolytic agents are used to prevent and treat hemorrhage, there are concerns about a potential increased risk for peripartum venous thromboembolism. We sought to determine the impact of tranexamic acid and ɛ-aminocaproic acid on in vitro clotting properties in pregnancy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom